0001193125-22-194938.txt : 20220816 0001193125-22-194938.hdr.sgml : 20220816 20220715160659 ACCESSION NUMBER: 0001193125-22-194938 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: biote Corp. CENTRAL INDEX KEY: 0001819253 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 851791125 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1875 W. WALNUT HILL LN #100 CITY: IRVING STATE: TX ZIP: 75038 BUSINESS PHONE: 972-486-9346 MAIL ADDRESS: STREET 1: 1875 W. WALNUT HILL LN #100 CITY: IRVING STATE: TX ZIP: 75038 FORMER COMPANY: FORMER CONFORMED NAME: Haymaker Acquisition Corp. III DATE OF NAME CHANGE: 20200727 CORRESP 1 filename1.htm CORRESP

BIOTE CORP.

1875 W. Walnut Hill Ln #100

Irving, TX 75038

 

July 15, 2022    VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Daniel Crawford and Laura Crotty

RE:   biote Corp.

Registration Statement on Form S-1

File No. 333-265714

Acceleration Request

Requested Date:      July 19, 2022

Requested Time:     4:05 P.M. Eastern Time

Ladies and Gentlemen:

biote Corp. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) to become effective on July 19, 2022, at 4:05 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Ryan Sansom and Peter Byrne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Peter Byrne, counsel to the Registrant, at (212) 479-6778.

Very truly yours,

biote Corp.

 

/s/ Robbin Gibbins
Robbin Gibbins
Chief Financial Officer

cc:     Ryan Sansom, Cooley LLP

Peter Byrne, Cooley LLP